Company Filing History:
Years Active: 2015
Title: Chang Geng Peng: Innovator in Chemical Modifications
Introduction
Chang Geng Peng is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of chemical modifications, particularly in the area of oligonucleotides. His work has implications for treating various medical conditions, showcasing the intersection of chemistry and healthcare.
Latest Patents
Chang Geng Peng holds 1 patent for his invention titled "Chemical modifications of monomers and oligonucleotides with cycloaddition." This invention features compounds of formula I or II. In one embodiment, it relates to compounds and processes for conjugating ligands to oligonucleotides. The invention further addresses methods for treating various disorders and diseases, including viral infections, bacterial infections, parasitic infections, cancers, allergies, autoimmune diseases, immunodeficiencies, and immunosuppression.
Career Highlights
He is currently employed at Alnylam Pharmaceuticals, Inc., where he continues to advance his research and innovations. His work at this leading biopharmaceutical company allows him to contribute to the development of transformative therapies.
Collaborations
Chang Geng Peng has collaborated with esteemed colleagues such as Muthiah Manoharan and Kallanthottathil G Rajeev. These partnerships enhance the scope and impact of his research.
Conclusion
Chang Geng Peng is a prominent figure in the field of chemical modifications, with a focus on oligonucleotides and their applications in medicine. His innovative work has the potential to significantly improve treatment options for various diseases.